WaferGen Biosystems (WGBS.OB) Launches Early-access Program for Genotyping Technology

QualityStocks would like to highlight WaferGen Biosystems (OTCBB: WGBS), a leader in the development, manufacture, and sale of state-of-the-art systems for genomic analysis for the life science and pharmaceutical industries. The company currently offers the breakthrough SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform.

In the company’s news,

WaferGen Biosystems recently announced that it is offering an early-access program for high-throughput Single Nucleotide Polymorphism (SNP) Genotyping through its new SmartChip Real-Time PCR System.

The company said it issued the offering in response to consumer demand for increasing speed and needs of genomics researchers. The offering is part of the company’s overall expansion based on the commercial success of its SmartChip System as the company delves into the SNP genotyping market.

“SNP Genotyping screening with the SmartChip System opens a new and large market opportunity for us, as it is focused on a $300 million addressable human and agriculture biotechnology genotyping market, part of a total SNP genotyping market of approximately $2.8 billion. By improving on SNP genotyping throughput in a flexible and low-cost manner, the SmartChip System offers researchers the ability to adopt a simple workflow for their mid-density SNP screening projects,” Alnoor Shivji, chairman and CEO of WaferGen stated in the press release.

Shivji said the company’s strategy is to maximize, expand and fully utilize SmartChip System’s applications to address the workflow challenges in the modern genomics analysis workplace.

“As we work towards the full commercial launch of the SNP Genotyping application, we plan to continue to expand on the functionality and applicability of our SmartChip System beyond Gene Expression and SNP Genotyping. This will offer researchers the most productive and cost-effective genomic analysis products,” Shivji stated.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.